Navigation Links
CompleGen Announces Successful Delivery of Its XenoGene™ Technology to Boehringer Ingelheim for Drug Discovery Under a Non-Exclusive Agreement.
Date:1/17/2012

SEATTLE, Jan. 17, 2012 /PRNewswire/ -- CompleGen, Inc. announced today that they have executed a non-exclusive services agreement regarding CompleGen's XenoGene™ technology.  Boehringer Ingelheim's discovery team will apply the technology to explore targets that are not easily accessible by other discovery platforms.

CompleGen's XenoGene™ technology uses the power of genetics to identify allosteric inhibitors that are selective for specific protein targets.

"We are very pleased to be working with Boehringer Ingelheim to open pathways for therapeutics that have proved to be elusive previously," commented Pauline Gee, CompleGen's VP Business Development.

About CompleGen

CompleGen is a drug discovery company that uses its proprietary discovery platform, XenoGene™ technology to identify and develop selective inhibitors for difficult targets.  With its small molecule library, CompleGen has identified potent allosteric inhibitors for targets where other discovery platforms have failed.  These allosteric inhibitors have been shown to be efficacious and well tolerated in animals.  www.complegen.com

Contact:
Pauline Gee, PhD
Vice President, Business Development
CompleGen, Inc.
1124 Columbia Street, Suite 662
Seattle, WA 98104
pgee@complegen.com
+1.303.961.1773


'/>"/>
SOURCE CompleGen, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Incisive Surgical Announces Breakthrough Peer Review Clinical Study
2. Molnlycke Health Care U.S. Announces Senior Management Change
3. Zimmer Announces Acquisition of Synvasive Technology, Inc.
4. MiMedx Group, Inc. Board Announces Support for Chairman Parker H. "Pete" Petit
5. BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
6. Medical IT and Diagnostic Product Company Decision Diagnostics Announces Patent Enforcement Strategy for Their Smart Phone Based EMR Technology
7. Practice Fusion Announces New Funding to Support EMR Growth in 2012
8. LIQUENT Announces XEVMPD Educational Series and Data Assessment Tool
9. BNA Books Announces the Publication of the 2011 Cumulative Supplement to "Pharmaceutical Law: Regulation of Research, Development, and Marketing"
10. NewCardio Announces Changes in Board of Directors and Executive Management
11. RSB Spine, LLC, Announces United States Patent Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  True Health, ... has amplified its effort during National Breast Cancer ... hereditary cancer risks. ... Clinical Oncology calculated that more than 10 million ... inherited mutations in BRCA1 or BRCA2 and have not ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare product ... training aide "cprCUBE" on Kickstarter. The device will educate ... cardiac arrests with better efficiency compared to the dated ... real-time feedback on efficacy of the compression for a ... has a goal to raise $5,000. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Dickinson Insurance and Financial ... financial preparation services, is providing an update on a charitable event that began ... Rescue is a locally recognized nonprofit that provides shelter and care for animals ...
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's ... President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. ... 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with ... for the primary prevention of cardiovascular diseases during the 15th Annual Women’s ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun ... NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is ... is geared towards children of all ages; it is a non-competitive, non-timed event, which ...
Breaking Medicine News(10 mins):